跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
鄭 凱比
Doctor
內科部
電子郵件
supercabyhome
yahoo.com
tw
h-index
89
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2018
2024
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(14)
類似的個人檔案
(6)
指紋
查看啟用 Kai-Pi Cheng 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Hedgehog Proteins
92%
Sarcopenia
91%
secretogranin III
72%
type 1 taste receptors
69%
Non-Nutritive Sweeteners
65%
trichlorosucrose
61%
Overweight
56%
High Fat Diet
56%
Growth Differentiation Factor 15
55%
Proprotein Convertases
54%
Subtilisin
52%
Obese Mice
52%
Non-alcoholic Fatty Liver Disease
49%
Glucagon-Like Peptide-1 Receptor
47%
Liver
47%
Prediabetic State
47%
Hyperlipoproteinemia Type II
45%
Fasting
42%
Obesity
42%
Myoblasts
42%
Glucose
41%
Unsaturated Fatty Acids
39%
Helicobacter Infections
39%
Serum
38%
Oleic Acid
36%
Insulin
36%
Helicobacter pylori
35%
Biomarkers
34%
Liver Diseases
34%
Hyperglycemia
33%
Weights and Measures
29%
Frailty
29%
Insulin Resistance
29%
Skeletal Muscle
25%
Pylorus
23%
Linear Models
22%
Regression Analysis
21%
Breath Tests
19%
Hypoglycemic Agents
19%
Hemoglobins
18%
Fatty Acids
17%
C-Reactive Protein
17%
Infections
17%
Blood Pressure
17%
Lipogenesis
16%
Chemical Compounds
Insulin Derivative
100%
Glucagon-Like Peptide-1 Receptor Agonist
71%
Small Interfering RNA
50%
Glycogen
43%
Weight
43%
Unsaturated Fatty Acid
42%
Metabolic
39%
Microarrays
39%
Lipid
35%
Resistance
26%
Inosine
22%
High-Density Lipoprotein Cholesterol
19%
Pyruvate
19%
Fatty Acid
17%
Stattic
16%
Blood Pressure
15%
Hemoglobin
15%
Cell Viability
14%
Biological Marker
13%
Glucose
13%
Triglyceride
12%
Oil Red O
12%
Protective
12%
Alanine
11%
Filtration
10%
Body Weight Change
8%
Linoleic Acid
8%
Liraglutide
7%
Glycemic
6%
Protein
5%
Agriculture & Biology
fatty liver
90%
nonnutritive sweeteners
64%
sucralose
56%
artificial sweeteners
54%
liver diseases
54%
taste receptors
49%
high fat diet
47%
mice
21%
liver
19%
endoplasmic reticulum stress
17%
lipogenesis
16%
glycogen
13%
reactive oxygen species
11%
RNA editing
9%
adenosine deaminase
9%
obesity
9%
disease progression
9%
inosine
9%
hyperlipidemia
9%
insulin resistance
8%
chronic diseases
8%
gluconeogenesis
8%
synthesis
8%
lipids
7%
adenosine
7%
pyruvates
7%
droplets
6%
pretreatment
6%
insulin
6%
sweeteners
5%
